Visualization of the photodegradation of a therapeutic drug by chemometric-assisted fluorescence spectroscopy

Masaru Tanioka, Tsugumi Ebihana, Manae Uraguchi, Haruka Shoji, Yuka Nakamura, Rina Ueda, Shota Ogura, Yoshifumi Wakiya, Tohru Obata, Takahiro Ida, Jun Horigome, Shinichiro Kamino*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The fluorescence spectral fingerprint, also known as the excitation-emission matrix (EEM), is used to assess and visualize therapeutic drug photodegradation in combination with chemometrics. Examination of EEM-parallel factor analysis (PARAFAC) data showed that an individual component was easily separated from a mixture of photogenerated products of a heterocyclic pharmacophore, in this case, phenothiazine drugs (PTZs). Detailed investigations of both structure-EEM relationships and kinetics revealed that the components extracted from EEM-PARAFAC could be quantitatively attributed to such photogenerated products as phenothiazine sulfoxide and carbazole derivatives. EEM in combination with principal component analysis (PCA) could be used as a mapping tool to visualize information of the photodegradation process of PTZs. We also assessed the photostability of various types of PTZs containing side chains by using validated EEM-PARAFAC methodology.

Original languageEnglish
Pages (from-to)20714-20720
Number of pages7
JournalRSC Advances
Volume12
Issue number32
DOIs
StatePublished - 2022/07/19

ASJC Scopus subject areas

  • General Chemistry
  • General Chemical Engineering

Fingerprint

Dive into the research topics of 'Visualization of the photodegradation of a therapeutic drug by chemometric-assisted fluorescence spectroscopy'. Together they form a unique fingerprint.

Cite this